<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 30, 2000
AMERICAN BIO MEDICA CORPORATION
------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
---------------------------- ------------------------ ----------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
122 Smith Road, Kinderhook, New York 12106
--------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
Not Applicable
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
ITEM 5. OTHER EVENTS
The Common Stock Purchase Agreement that the Company entered into with
Seaside Partners in connection with the private placement of 1,408,450 common
shares for $2,000,000 on April 28, 2000 provided that the Company was obligated
to register these shares by filing a registration statement with the SEC and to
have the registration statement declared effective by October 28, 2000. The
Common Stock Purchase Agreement further provided that the Company would be
obligated to pay to Seaside Partners liquidated damages in an amount equal to
five percent per month (or any part thereof), compounded monthly on $2,000,000
for the period beginning on October 29, 2000 and ending on the date the
registration statement is declared effective by the SEC. The Company currently
expects that the registration statement will be declared effective on November
30, 2000 resulting in the Company being obligated to pay liquidated damages of
approximately $110,000 to Seaside Partners. The Company is currently negotiating
with Seaside Partners to either waive or reduce the liquidated damages.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION
(Registrant)
Dated: November 30, 2000 By: /s/ Stan Cipkowski
-------------------------------------
Stan Cipkowski,
Chairman of the Board, President and
Chief Executive Officer
3
